BUGDF (Bumrungrad Hospital PCL) EPS without NRI: $0.27 (TTM As of Dec. 2025)


BUGDF Bumrungrad Hospital PCL BUGDF
100 GF Score
Price $4.75
GF Value $5.79
! 1 Warning Sign
View Full Analysis

What is Bumrungrad Hospital PCL EPS without NRI?

Bumrungrad Hospital PCL BUGDF 100 EPS without NRI is $0.27 as of Dec. 2025. GuruFocus rates BUGDF with a GF Score™ of 100/100 and a GF Value™ of $5.79. The stock has 1 warning sign investors should review. Among 511 Healthcare Providers & Services companies, Bumrungrad Hospital PCL ranks better than 55.58% on this metric.

Bumrungrad Hospital PCL's earnings per share without non-recurring items for the three months ended in Dec. 2025 was $0.07. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $0.27.

During the past 12 months, Bumrungrad Hospital PCL's average earnings per share (NRI) Growth Rate was -3.40% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 15.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 53.40% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Bumrungrad Hospital PCL's EPS without NRI or its related term are showing as below:

BUGDF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -32.8   Med: 11.4   Max: 83.4
Current: 15.1

During the past 13 years, Bumrungrad Hospital PCL's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 83.40% per year. The lowest was -32.80% per year. And the median was 11.40% per year.

BUGDF's 3-Year EPS without NRI Growth Rate is ranked better than
55.58% of 511 companies
in the Healthcare Providers & Services industry
Industry Median: 11.3 vs BUGDF: 15.10

Bumrungrad Hospital PCL's EPS (Diluted) for the three months ended in Dec. 2025 was $0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.27.

Bumrungrad Hospital PCL's EPS (Basic) for the three months ended in Dec. 2025 was $0.08. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.29.


Bumrungrad Hospital PCL  (OTCPK:BUGDF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Bumrungrad Hospital PCL EPS without NRI Related Terms


Bumrungrad Hospital PCL EPS without NRI Historical Data

* Premium members only.

The historical data trend for Bumrungrad Hospital PCL's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bumrungrad Hospital PCL EPS without NRI Chart

Bumrungrad Hospital PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.16 0.23 0.26 0.28

Bumrungrad Hospital PCL Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.07 0.07 0.07

BUGDF vs HCA, THC, DVA: EPS without NRI Comparison

For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bumrungrad Hospital PCL PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Bumrungrad Hospital PCL's PE Ratio without NRI falls into.


BUGDF
100GF Score
Bumrungrad Hospital PCL BUGDF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bumrungrad Hospital PCL EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.27 mean?
Bumrungrad Hospital PCL (BUGDF) has a EPS without NRI of $0.27 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Bumrungrad Hospital PCL and its competitors. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #227 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 44.4%.
Is Bumrungrad Hospital PCL's EPS without NRI too high?
Bumrungrad Hospital PCL's current EPS without NRI is $0.27. The Healthcare Providers & Services industry median EPS without NRI is 11.30. Bumrungrad Hospital PCL's value of $0.27 is 97.6% below this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #227 out of 511 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's EPS without NRI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #227 out of 511 companies for EPS without NRI. This puts Bumrungrad Hospital PCL in the upper half of its industry. The industry median EPS without NRI is 11.30. Bumrungrad Hospital PCL's value of $0.27 is 97.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.30, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current EPS without NRI of $0.27 is 97.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Bumrungrad Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current EPS without NRI is $0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current EPS without NRI of $0.27. The stock's GF Value™ is $5.79, compared to a current price of $4.75 — trading 18% below its estimated fair value. The current EPS without NRI is $0.27 and 97.6% below the Healthcare Providers & Services industry median of 11.30. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current EPS without NRI is $0.27 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?

Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued. The current stock price of $4.75 is trading 18% below its estimated GF Value™ of $5.79.

Key valuation signals for BUGDF:

  • EPS without NRI: $0.27
  • GF Value™: $5.79 vs. price of $4.75 (18% below fair value)
  • GF Score™: 100/100 with 1 warning sign
  • Industry Position: 97.6% below the Healthcare Providers & Services median (#227 of 511)

No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bumrungrad Hospital PCL Business Description

Other Exchanges BH:ThailandBZ7A:Germany
Address 33 Soi 3 (Nana Nua) Sukhumvit Road, Klongtoey Nua Sub District, Wattana District, Bangkok, THA, 10110
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score

Get the complete analysis for BUGDF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.75
Price
$5.79
GF Value